Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS FEATURE

If a coronavirus vaccine arrives, can the world make enough?

Researchers warn production constraints and hoarding could limit SARS-CoV-2 vaccine supplies.
  1. Roxanne Khamsi
    View author publications

    You can also search for this author in PubMed  Google Scholar

A technician in a protective suit uses a glove box to handle vaccine vials

Research facilities at CureVac in Tübingen, Germany: one of dozens of firms now working on a coronavirus vaccine. Credit: Martin Storz/imageBROKER/Picture Alliance

As the world searches for a way to end the coronavirus pandemic, the race is on to find and produce a vaccine. Some optimistic forecasts suggest that one could be available in 12–18 months — but researchers are already warning that it might not be physically possible to make enough vaccine for everyone, and that rich countries might hoard supplies.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 580, 578-580 (2020)

doi: https://doi.org/10.1038/d41586-020-01063-8

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links